Results 11 to 20 of about 39,716 (256)

Mapping MOS-HIV to HUI3 and EQ-5D-3L in Patients With HIV [PDF]

open access: yesMDM Policy & Practice, 2017
Objectives: The Medical Outcomes Study HIV Health Survey (MOS-HIV) is frequently used in HIV clinical trials; however, scores generated from the MOS-HIV are not suited for cost-effectiveness analyses as they do not assign utility values to health states.
Vilija R. Joyce MS   +11 more
doaj   +7 more sources

A Comparison of the EQ-5D-3L and EQ-5D-5L [PDF]

open access: yesPharmacoEconomics, 2020
Introduction The EQ-5D-3L (3L) and EQ-5D-5L (5L) are both frequently used measures of health status. Previous studies have found the EQ-5D-5L to have superior measurement properties but no study has compared the two measures in a large general population
A. Thompson, A. Turner
semanticscholar   +4 more sources

Estimating the Relationship Between EQ-5D-5L and EQ-5D-3L: Results from a UK Population Study. [PDF]

open access: yesPharmacoeconomics, 2023
Objectives The aim of this study was to estimate the relationship between EQ-5D-3L and EQ-5D-5L, in both directions, using a single model. Methods An online survey containing both variants of EQ-5D, with randomised ordering, was administered to a large ...
Hernández Alava M, Pudney S, Wailoo A.
europepmc   +2 more sources

Health-related quality of life in Denmark on a relative scale: mini-catalogue of mean EQ-5D-3L index scores for 17 common chronic conditions [PDF]

open access: yesNordic Journal of Health Economics, 2016
In health economic evaluations the quality-adjusted life-year (QALY) is one of the preferred outcome measures. Catalogues of median-based decrements in EQ-5D-3L index scores for chronic conditions exist to inform economic evaluations but may not be ...
Anne Vingaard Olesen   +2 more
doaj   +3 more sources

A head-to-head comparison of the EQ-5D-3L index scores derived from the two EQ-5D-3L value sets for China. [PDF]

open access: yesHealth Qual Life Outcomes, 2022
Abstract Objective Two EQ-5D-3L (3L) value sets (developed in 2014 and 2018) co-exist in China. The study examined the level of agreement between index scores for all the 243 health states derived from them at both absolute and relative levels and compared the responsiveness of the two indices.
Zhang RY   +5 more
europepmc   +5 more sources

Evaluation of the EQ-5D-3L and 5L versions in low back pain patients

open access: yesHealth and Quality of Life Outcomes, 2021
Background The EuroQol EQ-5D is one of the most widely researched and applied patient-reported outcome measures worldwide. The original EQ-5D-3L and more recent EQ-5D-5L include three and five response categories respectively.
A. M. Garratt   +6 more
doaj   +2 more sources

Examining the Association Between Equity-Related Factors and EQ-5D-3L Health Utilities of Patients with Cancer [PDF]

open access: yesCurrent Oncology
Background: EQ-5D-3L health utilities inform health technology assessments in oncology, often derived from clinical trials enrolling highly selected populations, which may over-estimate real-world health utilities.
Teresa C. O. Tsui   +3 more
doaj   +2 more sources

EQ-5D-3L derived population norms for health related quality of life in Sri Lanka. [PDF]

open access: yesPLoS ONE, 2014
BACKGROUND: Health Related Quality of Life (HRQoL) is an important outcome measure in health economic evaluation that guides health resource allocations.
Sanjeewa Kularatna   +4 more
doaj   +5 more sources

Experience-based health state valuation using the EQ VAS: a register-based study of the EQ-5D-3L among nine patient groups in Sweden

open access: yesHealth and Quality of Life Outcomes, 2023
Background The EQ VAS component of the EQ-5D questionnaire has been used to assess patients’ valuation of their own health besides its use for self-reporting of overall health status. The objective of the present study was to identify patients’ valuation
Fitsum Sebsibe Teni   +5 more
doaj   +2 more sources

Psychometric properties of the EQ-5D-5L compared with EQ-5D-3L in cancer patients in Iran. [PDF]

open access: yesFront Oncol, 2022
Background and Objective Psychometric evidence to support the validity and reliability of the EuroQol-5 Dimensions (EQ-5D) in cancer patients is limited.
Moradi N   +4 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy